Patents Assigned to Yasoo Health, Inc.
  • Patent number: 7790190
    Abstract: Disclosed herein is an aqueous emulsion. The lipid phase of the emulsion includes a blend of a therapeutically effective concentration of a lipophile, a concentration of Vitamin E TPGS, and a concentration of linoleic acid. The presence of linoleic acid increases the solubilizing affect of Vitamin E TPGS on the lipophile and thus reduces the amount of Vitamin E TPGS that would otherwise be required in the aqueous emulsion.
    Type: Grant
    Filed: March 20, 2004
    Date of Patent: September 7, 2010
    Assignee: Yasoo Health, Inc.
    Inventors: Andreas M. Papas, Konstantinos A. Papas, Howard K. Hobbs, Warren Hopkins, William A. Clark
  • Patent number: 7696363
    Abstract: Disclosed is an improved method for preparing the isoflavonoid compound (+/?)-equol, the method comprising reducing an organic diester of the isoflavone daidzein under hydrogen-transfer conditions using palladium hydroxide catalyst.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 13, 2010
    Assignee: Yasoo Health Inc.
    Inventor: John A. Hyatt
  • Patent number: 7038067
    Abstract: A process of forming a d-tocotrienol from a (2S)-vinylchromane compound, through hydroboration of the (2S)-vinylchromane to provide an organoborane, followed by coupling the organoborane with a halogenated C-14 sidechain compound under conditions of palladium-catalyzed cross-coupling is taught. Methods for providing the (2S)-vinylchromane compound and the halogenated C-14 compound are disclosed.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: May 2, 2006
    Assignee: Yasoo Health, Inc.
    Inventors: Elias A. Couladouros, Andreas M. Papas, Vassilios I. Moutsos, Maria Lampropoulou
  • Patent number: 6716873
    Abstract: Disclosed are novel tocopherol ester compounds having the formula wherein X is a chain of 2 or 3 carbon atoms, e.g., ethylene and trimethylene, joining the 2 carbonyl groups to which they are bonded; and R1 is a group having the formula —Y—R4 wherein Y is a selenium, tellurium or sulfur atom and R4 is an alkyl, cycloalkyl or aryl radical. The tocopherol ester compounds of formula (I) exhibit antiproliferative and growth inhibitory effects on breast cancer cell lines.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: April 6, 2004
    Assignee: Yasoo Health Inc.
    Inventors: Anastasios Keramidas, Andreani Odysseos, Andreas Michael Papas